GARDASIL 9

Suspension for injection in pre-filled syringe, 30mcg/0.5ml + 40mcg/0.5ml + 60mcg/0.5ml + 40mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml

RxActive license

Active substance (INN)

human papillomavirus 9-valent vaccine (types 6, 11, 16, 18, 31, 33, 45, 52, 58), recombinant, adsorbed

Pharmaceutical form

Pharmaceutical formSuspension for injection in pre-filled syringe

Strength30mcg/0.5ml + 40mcg/0.5ml + 60mcg/0.5ml + 40mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml

PackagingUkupno 1 napunjeni injekcioni špric sa 0.5ml suspenzije za injekciju (sa 2 igle) u kartonskoj kutiji

ManufacturerMerck Sharp & Dohme B.V., Netherlands

Therapeutic groupAnti-infectives for systemic use (J07BM03)

Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA

Authorization dateNovember 10, 2025

Source: CInMED register